Sources told CNBC’s David Faber that a private equity firm’s prospective deal to acquire Walgreens Boots Alliance is “mostly dead,” The Wall Street Journal reported Jan. 27.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
